NCT00598676View on ClinicalTrials.gov

3 Limus Agent Eluting Stents With Different Polymer Coating

PHASE4CompletedINTERVENTIONAL
Enrollment

2,600

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions
Coronary Heart Disease
Interventions
DEVICE

biodegradable polymer Rapamycin-eluting stent

due to randomization, rapamycin-eluting stent with biodegradable polymer will be implanted

DEVICE

permanent polymer rapamycin-eluting stent (Cypher)

due to randomization, rapamycin-eluting stent with permanent polymer will be implanted

DEVICE

permanent polymer everolimus-eluting stent (Xience, Promus)

due to randomization, everolimus-eluting stent with permanent polymer will be implanted

Trial Locations (2)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

Medizinische Klinik, Klinikum rechts der Isar, München

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00598676 - 3 Limus Agent Eluting Stents With Different Polymer Coating | Biotech Hunter | Biotech Hunter